Breaking News, Promotions & Moves

WCG Appoints Sam Srivastava CEO

Srivastava will oversee all WCG global operations leveraging his 30 years of experience in the healthcare industry.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WCG, a provider of solutions to improve the quality and efficiency of clinical research, has appointed Sam Srivastava as Chief Executive Officer. Srivastava joins the company from NeueHealth, a tech enabled risk bearing care delivery company, where he also served as CEO. He succeeds Dr. Donald Deieso, upon his retirement.   Srivastava will oversee all WCG global operations. In a career spanning 30 years, Srivastava has been a recognized thought leader and strategist in the healthcare industry....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters